Delaying immune-stimulating drugs after chemotherapy led to fewer cases of severe bone pain, and a two-drug regimen increased progression-free survival in lung cancer.

by Marci A. Landsmann

In addition to protection from the coronavirus, mRNA-based COVID-19 vaccines may strengthen the effectiveness of immunotherapy.

by Sandra Gordon

Therapy may reduce a chemotherapy-induced platelet disorder, and PSMA PET scans may help people with suspected prostate cancer forgo a biopsy.

by Darlene Dobkowski

Treatment regimen approved for multiple myeloma, and people with melanoma who undergo sentinel node biopsy live longer.

by Thomas Celona

Some people with prostate cancer may not need hormone therapy, and colorectal cancer cases shift increasingly to younger adults.

by Eric Fitzsimmons

Exercise programs and individualized support can help survivors of all fitness levels reap the benefits of movement.

by Erin O’Donnell

Prostate cancer tumors contain a high concentration of microplastics, and cervical cancer rates vary by state.

by Thomas Celona

First tumor treating fields device for pancreatic cancer approved, and hair extension products often contain potentially dangerous chemicals.

by Thomas Celona

Cutaneous squamous cell carcinoma is usually curable, but not always.

by Alexandra Frost

Misinformation reaches most breast cancer survivors, and the FDA approves a treatment combination for platinum-resistant epithelial ovarian cancer.

by Eric Fitzsimmons